Women and dementia risk: what the two-thirds statistic actually means

Short answer: Almost two-thirds of Americans living with Alzheimer's are women — 4.5 million of the 7.4 million people aged 65 and over. But that is a prevalence figure: it counts who is alive with the condition, and age is by far the biggest risk factor, so a group that lives longer accumulates more cases. When researchers look instead at incidence — who newly develops dementia at a given age — the Alzheimer's Association's own 2026 report concludes that most US studies find no meaningful difference between women and men. What does differ, and differ substantially, is which modifiable risk factors women tend to carry and how strongly some of them track with cognition. Those are the parts you can act on.

This is educational, not medical advice. Nothing here diagnoses anything or predicts whether you will develop dementia. Decisions about hormones, blood pressure, diabetes, hearing or medication belong with a clinician who knows your history.

Where the two-thirds number comes from — and what it hides

The statistic is real and it comes from a reliable source. In the Alzheimer's Association's 2026 Alzheimer's Disease Facts and Figures, of the 7.4 million Americans aged 65 and over living with clinical Alzheimer's dementia, 4.5 million are women and 2.9 million are men — 13% of women in that age group and 10% of men.

Almost every article you'll find on this question opens with that number and then explains it with biology: oestrogen, the APOE4 gene, the X chromosome. What almost none of them mention is the paragraph that follows it in the source document.

The Association writes that older age is the greatest risk factor, that women live longer than men on average, and that this survival difference contributes to the higher prevalence — and then, plainly:

"However, it is not clear that the risk of developing Alzheimer's or other dementias differs between men and women of the same age. Most studies of incidence in the United States have found no meaningful difference between men and women in the proportion who develop Alzheimer's or other dementias at any given age."

That distinction matters more than any other sentence on this page.

Prevalence counts who is alive with a condition. Incidence counts who newly develops it. Because dementia risk rises steeply with age and women live longer, women accumulate more of the cases even if the per-year risk at any given age is similar. The picture outside the US is genuinely mixed — some European studies find a higher rate in women at older ages, others find a higher rate in men, and one multi-country study found a female excess that was more pronounced in low- and middle-income countries.

There's a second wrinkle the same report raises. Men die of cardiovascular disease at higher rates in midlife, so the men who survive to 65 and enter these studies are a selected group with healthier hearts — which may make men's later dementia risk look artificially low. The Association is careful to add that "more research is needed to support this interpretation," and so are we.

None of this makes the concern silly. A woman's estimated lifetime risk of Alzheimer's from age 45 is about 1 in 5, against roughly 1 in 10 for a man — an estimate from Framingham Heart Study data. But notice that a lifetime risk contains the same longevity effect. It is a real number about a real difference in how lives unfold. It is not evidence that being a woman is itself a switch that has been flipped against you.

So what does differ?

Here the picture is clearer, more recent, and much more useful — because most of it is modifiable.

In 2026, researchers at UC San Diego published an analysis in Biology of Sex Differences of 17,182 US adults in the Health and Retirement Study — mean age 69, 59% women — examining 13 established modifiable dementia risk factors: education, hearing loss, cholesterol, depression, physical inactivity, diabetes, smoking, high blood pressure, obesity, heavy alcohol use, social isolation, poor vision and poor sleep.

Three findings stand out.

First: ten of the thirteen factors differed by sex, and women carried more of them. Women had a higher prevalence of raised cholesterol, depression, physical inactivity, smoking, poor vision and poor sleep, and had fewer years of education. Men had more hearing loss, diabetes and heavy alcohol use.

Second: three factors — hearing loss, diabetes and high blood pressure — were associated with a larger negative effect on cognition in women than in men with the same condition. Obesity showed the same pattern in women in their fifties and sixties, though not at older ages. As first author Megan Fitzhugh put it, prevention "may be more effective if tailored not just to risk factor prevalence, but to how strongly each factor affects cognition in women versus men."

Third, and more encouraging: it cuts both ways. Education and cholesterol had stronger positive associations with cognitive performance in women than in men — meaning the things that help may also count for more.

Two honest caveats, because they change how much weight this carries. The outcome measured was a cognitive test score, not a dementia diagnosis — a related thing, not the same thing. And the design compares people at a point in time, so it shows an association rather than proving that treating your blood pressure changes your cognition. It is a strong signal about where to look, not proof of cause.

Alongside the biology sits something less often discussed: gender, not just sex. The Association's report notes that women born in the first half of the twentieth century typically had less formal education than men — and lower educational attainment is itself a dementia risk factor, with some evidence that the association is stronger in women. It also notes that women who joined the paid workforce earlier in life had better cognitive outcomes after 60 than those who did not. Those are facts about a particular generation's circumstances, not about female brains.

The three questions women actually ask

"Does menopause cause dementia?"

No — but the age it happens is associated with risk, and it's one of the better-evidenced women's factors we have. In a study of 233,802 women published in Age and Ageing in November 2024, menopause before 40 was associated with a 47% higher dementia rate (aHR 1.47, 95% CI 1.39–1.56) and menopause at 40–44 with 28% higher (aHR 1.28, 1.17–1.40), compared with menopause at a typical age.

The same study delivered a surprise that is worth knowing if you have had surgery: the type of menopause was not what predicted risk. Surgical menopause showed essentially no association once age was accounted for (aHR 0.99, 0.93–1.04). We unpack that in detail in hysterectomy, ovary removal and dementia risk.

And if what you're experiencing right now is fog, forgetfulness and lost words in your forties or fifties, the far more likely explanation is the transition itself: menopause brain fog vs dementia.

"Should I take HRT to protect my brain?"

No — decide HRT on your symptoms, not on your brain. The largest review to date, commissioned by the WHO and published in Lancet Healthy Longevity in December 2025, pooled 10 studies and 1,016,055 participants and found no significant association between menopause hormone therapy and dementia or mild cognitive impairment — in either direction. Subgroup analyses by timing, duration and type were also null. The WHO's 2026 guidelines advise against taking HRT solely to reduce dementia risk.

HRT can be an excellent treatment for menopausal symptoms, and that conversation is worth having with your clinician. It is just not a brain-protection strategy. The full story — including why the FDA changed its warning in November 2025, and why the replacement message overshoots — is in HRT and dementia risk.

"Is APOE4 worse for women?"

Less clearly than you've probably read. The widely-quoted claim — that APOE4 raises dementia risk 81% in women but only 27% in men — comes from a 2014 analysis of one research cohort. Larger studies have qualified it substantially.

A meta-analysis of 27 studies and roughly 58,000 people (JAMA Neurology, 2017) found no overall difference between women and men across ages 55–85 — the female excess appeared only between about 65 and 75. A later analysis of 68,756 people across four ancestry groups (JAMA Neurology, 2023) replicated that pattern and placed the window at ages 60–70. The Alzheimer's Association reaches the same conclusion in its 2026 report.

So: a real, replicated, age-restricted interaction — not a blanket doubling of your risk because you are a woman. If you're weighing whether to find out your genotype at all, we wrote a whole post on that decision: should I get the Alzheimer's gene test?

And here is the finding that matters most if you carry it. Pooling three multidomain lifestyle trials — FINGER, J-MINT and MAPT — researchers reported in December 2025 that APOE4 carriers benefited more from structured lifestyle change than non-carriers (interaction p = 0.035). The authors call it preliminary. It is still the best answer we have to "what's the point if it's in my genes."

What to actually do about it

The unglamorous truth is that the strongest levers for women are the same ones the 2024 Lancet Commission identifies for everyone — the 14 modifiable factors linked to around 45% of dementia cases worldwide. What this week's evidence adds is a reason to take three of them especially seriously, because they appear to track more strongly with women's cognition:

1. Hearing. The single most under-treated factor on the list. Untreated hearing loss is associated with higher dementia risk, and a hearing test costs an afternoon. → hearing loss and dementia
2. Blood pressure. Midlife blood pressure is one of the best-evidenced levers there is. Worth a reading and a conversation with your GP. → blood pressure and dementia
3. Blood sugar. Type 2 diabetes and pre-diabetes both matter, and both are manageable. → blood sugar and dementia

Then the factors where women showed the higher burden in the 2026 analysis:

1. Depression — the widest gap found (17% vs 9%). Treatable, and worth treating on its own merits. → is it anxiety or dementia?
2. Physical activity — → exercise and dementia
3. Sleep — → sleep and dementia risk
4. Social connection — → loneliness and dementia

Plus the ones that apply regardless of sex: cholesterol, vision, smoking, alcohol and what you eat.

That's a long list, which is exactly the problem with lists.

The thing worth taking away

The two-thirds statistic is true, widely repeated, and widely misunderstood. It describes a population, and most of what it describes is that women live longer in a condition where age dominates everything else.

What it does not say is that you have been dealt a losing hand. The differences that show up when researchers look closely are mostly differences in risk factors — hearing, blood pressure, blood sugar, mood, movement, sleep, connection — and risk factors are the part of this you can do something about.

More context: can you reduce your dementia risk? · the 2024 Lancet Commission's 14 factors · check your dementia risk · what the WHO now says

How we research and review our content →

This article is educational and is not medical advice, diagnosis, or treatment. The studies cited describe findings in general populations, not any individual. Solenna is not a medical device and does not diagnose, prevent, treat, or cure Alzheimer's disease or any other condition. Risk reduction means lowering probability, not eliminating it; individual results vary and no outcome is guaranteed. Decisions about hormone therapy, blood pressure, diabetes, medication or genetic testing should be made with a qualified clinician.